MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$61,922 | -$32,563 | -$26,135 |
| Dep. & Amort. | $244 | $157 | $56 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $5,222 | $2,043 | $306 |
| Change in WC | $4,597 | -$735 | $1,290 |
| Other Non-Cash | -$2,822 | -$880 | $1,361 |
| Operating Cash Flow | -$54,681 | -$31,978 | -$23,122 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$874 | -$129 | -$441 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$239,471 | -$63,798 | -$20,220 |
| Inv. Sales/Matur. | $79,750 | $33,000 | $9,250 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$160,595 | -$30,927 | -$11,411 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $10,000 |
| Stock Issued | $174,542 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $59,562 | $69,218 | $36,063 |
| Financing Cash Flow | $234,104 | $69,218 | $46,063 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $18,828 | $6,313 | $11,530 |
| Supplemental Information | – | – | – |
| Beg. Cash | $30,523 | $24,210 | $12,680 |
| End Cash | $49,351 | $30,523 | $24,210 |
| Free Cash Flow | -$55,555 | -$32,107 | -$23,563 |